First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L)
FBT.L is a passive ETF by First Trust tracking the investment results of the NASDAQ Biotechnology TR USD. FBT.L launched on May 27, 2020 and has a 0.60% expense ratio.
ETF Info
| ISIN | IE00BL0L0H60 |
|---|---|
| WKN | A2PZBP |
| Issuer | First Trust |
| Inception Date | May 27, 2020 |
| Category | Health & Biotech Equities |
| Index Tracked | NASDAQ Biotechnology TR USD |
| Domicile | Ireland |
| Distribution Policy | Accumulating |
| Asset Class | Equity |
Asset Class Size | Mid-Cap |
Asset Class Style | Growth |
Expense Ratio
The First Trust NYSE Arca Biotechnology UCITS ETF Acc has a high expense ratio of 0.60%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in First Trust NYSE Arca Biotechnology UCITS ETF Acc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
First Trust NYSE Arca Biotechnology UCITS ETF Acc had a return of -6.53% year-to-date (YTD) and -6.56% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -6.53% | 6.33% |
| 1 month | -3.31% | -2.81% |
| 6 months | 4.40% | 21.13% |
| 1 year | -6.56% | 24.56% |
| 5 years (annualized) | N/A | 11.55% |
| 10 years (annualized) | N/A | 10.55% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -5.30% | 1.65% | 1.80% | |||||||||
| 2023 | -1.80% | -9.70% | 3.19% | 11.36% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
First Trust NYSE Arca Biotechnology UCITS ETF Acc(FBT.L)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the First Trust NYSE Arca Biotechnology UCITS ETF Acc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the First Trust NYSE Arca Biotechnology UCITS ETF Acc was 30.39%, occurring on Jun 16, 2022. The portfolio has not yet recovered.
The current First Trust NYSE Arca Biotechnology UCITS ETF Acc drawdown is 18.63%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -30.39% | Jul 21, 2020 | 469 | Jun 16, 2022 | — | — | — |
| -3.87% | Jun 1, 2020 | 10 | Jun 12, 2020 | 4 | Jun 18, 2020 | 14 |
| -3.35% | Jul 8, 2020 | 5 | Jul 14, 2020 | 3 | Jul 17, 2020 | 8 |
| -2.15% | Jun 29, 2020 | 2 | Jun 30, 2020 | 2 | Jul 2, 2020 | 4 |
| -0.75% | Jun 24, 2020 | 1 | Jun 24, 2020 | 1 | Jun 25, 2020 | 2 |
Volatility
Volatility Chart
The current First Trust NYSE Arca Biotechnology UCITS ETF Acc volatility is 3.56%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.